Aurobindo Pharma has informed that the compensation committee of directors of the company at its meeting held on December 16, 2011, has considered and approved grant of 12,05,000 options at an exercise price of Rs. 91.60 per option (each option confer a right to one equity share of Re. 1 each) under the Employees Stock Option Plan, 2006.
The above information is part of the company’s filing submitted to the BSE.